|
|
|
|
Polyphenon Pharma is a privately held subsidiary of the Japanese company,
Mitsui Norin Co., Ltd., which discovered and manufactures Polyphenon E®. The financial backing provided to the Company by its parent company and investors enables it to aggressively pursue the preclinical and early clinical development of Polyphenon E in multiple
disease states.
Established in the United States in March 25, 2005, with headquarters in New York, NY, Polyphenon Pharma’s strategy is to leverage its broad intellectual property and research experience related to Polyphenon E across multiple market opportunities and unmet medical needs. The Company’s two-stage approach to pursuing the full potential of Polyphenon E is to use its own resources to advance drug candidates through Phase II clinical trials or proof-of-concept studies and then seek global pharmaceutical partners to complete late-stage development and commercialization in multiple countries.
 |
